Skip to content

Clinical Characteristics and Treatment Outcomes of Patients with Acute Lymphoblastic Leukemia in Thailand: a Multicenter study

Clinical Characteristics and Treatment Outcomes of Patients with Acute Lymphoblastic Leukemia in Thailand: a Multicenter study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20201021001
Enrollment
150
Registered
2020-10-21
Start date
2020-10-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Current treatment for acute lymphoid leukemia in Thailand There are a variety of chemotherapy regimens used in treatment according to the expertise of the treating physician. With no information that According to research abroad for the past 5&#45

Interventions

Patients 18 years of age and older with a doctor&#39
s diagnosis of new acute lymphoid leukemia. Which has the level of white blood cells (blast) in the bone marrow or in the bloodstream From 20 percent.
Diagnostic

Sponsors

Siriraj Hospital Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients 18 years of age and older with a doctor's diagnosis of new acute lymphoid leukemia. Which has the level of white blood cells (blast) in the bone marrow or in the bloodstream From 20 percent or more during 1 January 2013 - 31 December 2022

Exclusion criteria

Exclusion criteria: The patients with acute lymphoid leukemia who have a history of receiving chemotherapy from other hospitals. The patients with recurrent acute lymphoid leukemia or patients who have refused treatment. Participated in the study. The patients with chronic myeloid leukemia with lymphoid blast crisis. The patients with therapy related ALL.

Design outcomes

Primary

MeasureTime frame
Incidence of Acute Lymphoblastic Leukemia in Thailand 5 years Number ALL patients per normal population

Secondary

MeasureTime frame
Overall survival 5 years Survival analysis and Hazard ratio

Countries

Thailand

Contacts

Public ContactWeerapat Owattanapanich

Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol Unive

weerapato36733@gmail.com089-108-1983

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026